The discovery of a novel orally available CCR5 antagonist, as a therapeutic for HIV-1 infection

被引：0
|
作者：
Nogi, Rena Nishizawa
Nishiyama, Toshihiko
Hisaichi, Katsuya
Minamoto, Chiaki
Matsunaga, Naoki
Hirai, Keisuke
Habashita, Hiromu
Takaoka, Yoshikazu
Toda, Masaaki
Takahashi, Eiji
Imawaka, Haruo
Sagawa, Kenji
Shibayama, Shiro
Fukushima, Daikichi
Maeda, Kenji
Mitsuya, Hiroaki
机构：
[1] ONO PHARMACEUT CO LTD, Dept Med Chem, Mishima, Osaka 6188585, Japan
[2] ONO PHARMACEUT CO LTD, Pharmacokinet Res Labs, Mishima, Osaka 6188585, Japan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
385-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    PLOS ONE, 2008, 3 (07):
  • [22] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    AIDS, 2008, 22 (16) : 2212 - 2214
  • [23] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
  • [24] HIV-1 infection in an individual homozygous for the CCR5 deletion allele
    Robyn Biti
    Rosemary Ffrench
    Judy Young
    Bruce Bennetts
    Graeme Stewart
    Tong Liang
    Nature Medicine, 1997, 3 : 252 - 253
  • [25] HIV-1 infection in an individual homozygous for CCR5 Delta 32
    Theodorou, I
    Meyer, L
    Magierowska, M
    Katlama, C
    Rouzioux, C
    LANCET, 1997, 349 (9060): : 1219 - 1220
  • [26] HIV-1 infection in an individual homozygous for the CCR5 deletion allele
    Biti, R
    French, RF
    Young, J
    Bennetts, B
    Stewart, G
    Liang, T
    NATURE MEDICINE, 1997, 3 (03) : 252 - 253
  • [27] HIV-1 infection in a man homozygous for CCR5 Delta 32
    OBrien, TR
    Winkler, C
    Dean, M
    Nelson, JAE
    Carrington, M
    Michael, NL
    White, GC
    LANCET, 1997, 349 (9060): : 1219 - 1219
  • [28] Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection
    Herrera-Carrillo, Elena
    Ben Berkhout
    PLOS ONE, 2017, 12 (05):
  • [29] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [30] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
12345